Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Johnson and Johnson
UBS
Moodys
Express Scripts
Argus Health
Harvard Business School
McKinsey
Dow
Federal Trade Commission

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078163

« Back to Dashboard
NDA 078163 describes TERBINAFINE HYDROCHLORIDE, which is a drug marketed by Taro, Breckenridge Pharm, Harris Pharm, Roxane, Wockhardt, Invagen Pharms, Mylan, Cipla Ltd, Glenmark Generics, Orchid Hlthcare, Gedeon Richter Usa, Teva, Dr Reddys Labs Inc, Aurobindo Pharma, and Apotex, and is included in sixteen NDAs. It is available from fifty-two suppliers. Additional details are available on the TERBINAFINE HYDROCHLORIDE profile page.

The generic ingredient in TERBINAFINE HYDROCHLORIDE is terbinafine hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the terbinafine hydrochloride profile page.

Summary for NDA: 078163

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details

Pharmacology for NDA: 078163

Ingredient-typeAllylamine

Suppliers and Packaging for NDA: 078163

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL 078163 ANDA Northstar Rx LLC 16714-501 16714-501-01 30 TABLET in 1 BOTTLE, PLASTIC (16714-501-01)
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL 078163 ANDA Northstar Rx LLC 16714-501 16714-501-02 100 TABLET in 1 BOTTLE, PLASTIC (16714-501-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 250MG BASE
Approval Date:Jul 2, 2007TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Covington
Queensland Health
Citi
Healthtrust
McKinsey
Chinese Patent Office
Cipla
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot